Category: Singapore Exchange

Corporate Sector, Industry, Singapore Exchange, News Releases

Carlos de Sousa appointed CEO of Ultimovacs ASA

OSLO: Ultimovacs ASA, a pharmaceutical company developing novel immunotherapies against cancer, announces that Carlos de Sousa, MD, has been appointed as the new Chief Executive...